Re.engineer Magazine - Summer 2021

S H I F T E C H

Logan Thrasher Collins

Logan Thrasher Collins is the Chief Technology Officer (CTO) at Conduit, a PhD candidate in biomedical engineering, and a published science fiction author. When Logan was 16 years old, he invented a de novo antimicrobial peptide and bacterial conjugation delivery system as a new way of combating antibiotic resistant infections. His proof-of-concept for this synthetic biology research was recognized with several major awards at the Intel International Science and Engineering Fair (ISEF), a TEDx talk at TEDxMileHigh 2014, high honors at the International BioGENEius Challenge, and a trip to attend the Nobel Prize ceremonies through the Stockholm International Youth Science Seminar. As part of his honors at Intel ISEF, a minor planet was named Logancollins. Logan continued to pursue scientific research during college. After he obtained some further experimental validation, his antimicrobial synthetic biology research was published in the scientific journal ACS Biochemistry. He then went on to a new project and developed a nanotechnology-based contrast agent for x-ray microtomography imaging of brain tissue. For this neuroscience research, he was awarded the prestigious Beckman scholarship. In addition, Logan’s review paper on insect brain simulation was published in the scientific journal Biological Cybernetics. Logan graduated summa cum laude in molecular biology and summa cum laude in neuroscience. Logan joined Conduit at the beginning of the COVID-19 pandemic. As one of his first actions at Conduit, he wrote a proposal for using supercomputers to study SARS-CoV-2 and thereby to better understand how to combat COVID-19. His proposal was soon accepted by the White House’s COVID-19 High-Performance Computing Consortium. Conduit was granted access to Frontera, one of the world’s most powerful supercomputers. Logan led a team of software engineers and computational chemists to implement simulations which have revealed insights around the biology of SARS-CoV-2. His team is currently performing quantitative data analysis to help obtain further insights from the simulations. Logan also invented the technology underlying Conduit’s home diagnostic (nanoSPLASH) and is collaborating with a team at Avomeen to make this technology a reality. Since he is deeply passionate about the interface between the arts and the sciences, Logan writes sci-fi poetry and science fiction. His poetry has been published in Andromeda Spaceways Magazine, Abyss & Apex Magazine, Mithila Review, Silver Blade Magazine, and elsewhere. His short fiction has been published in The Centropic Oracle, After Dinner Conversation, Theme of Absence, and elsewhere. In the long term, Logan plans to obtain a position as a professor at a major research university. He also plans to collaborate with industry to bring his research towards real-world applications. Logan’s primary goals are to positively impact people’s lives with his inventions and discoveries and to help protect the long-term future of humanity.

THE UNIVERSE IS LIKE A N OPEN BOX OF LEGO BRICKS , RE A DY FOR RECONFIGUR A TION INTO A NIGH - INFINITE DIVERSITY OF FORMS . BEC A USE I A M A SYNTHETIC BIOLOGIST , I H A VE THE NECESS A RY SKILLS TO RE A RR A NGE THE BUILDING BLOCKS OF BIOLOGIC A L SYSTEMS A ND TO CRE A TE BE A UTIFUL NEW INVENTIONS WHICH H A VE THE POTENTI A L TO HELP OTHERS . I LOVE TO CRE A TE A ND TO HELP PEOPLE .

FOR ME , SCIENCE REPRESENTS A N INTENSELY EXCITING A ND DEEPLY FULFILLING A DVENTURE .

As someone who is a dreamer at heart, Logan loves how science provides the tools necessary to create technologies which can change people’s lives for the better.

Powered by